138 related articles for article (PubMed ID: 12375029)
1. Clinical significance of ST3Gal IV expression in human renal cell carcinoma.
Saito S; Yamashita S; Endoh M; Yamato T; Hoshi S; Ohyama C; Watanabe R; Ito A; Satoh M; Wada T; Paulson JC; Arai Y; Miyagi T
Oncol Rep; 2002; 9(6):1251-5. PubMed ID: 12375029
[TBL] [Abstract][Full Text] [Related]
2. Human alpha2,3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase.
Saito S; Aoki H; Ito A; Ueno S; Wada T; Mitsuzuka K; Satoh M; Arai Y; Miyagi T
J Biol Chem; 2003 Jul; 278(29):26474-9. PubMed ID: 12716912
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
4. Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression.
Kono M; Ohyama Y; Lee YC; Hamamoto T; Kojima N; Tsuji S
Glycobiology; 1997 Jun; 7(4):469-79. PubMed ID: 9184827
[TBL] [Abstract][Full Text] [Related]
5. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
[TBL] [Abstract][Full Text] [Related]
6. Altered mRNA expressions of sialyltransferases in human gastric cancer tissues.
Jun L; Yuanshu W; Yanying X; Zhongfa X; Jian Y; Fengling W; Xianjun Q; Kokudo N; Wei T; Weixia Z; Shuxiang C
Med Oncol; 2012 Mar; 29(1):84-90. PubMed ID: 21140242
[TBL] [Abstract][Full Text] [Related]
7. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in peripheral blood mononuclear cells in systemic sclerosis.
Launay D; Peyrat JP; Verdière A; Hornez L; Hatron PY; Hachulla E; Devulder B; Hebbar M
J Rheumatol; 2004 Jan; 31(1):88-95. PubMed ID: 14705225
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma.
Bai Q; Liu L; Xia Y; Long Q; Wang J; Xu J; Guo J
BMC Cancer; 2015 Nov; 15():880. PubMed ID: 26552809
[TBL] [Abstract][Full Text] [Related]
9. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.
Videira PA; Correia M; Malagolini N; Crespo HJ; Ligeiro D; Calais FM; Trindade H; Dall'Olio F
BMC Cancer; 2009 Oct; 9():357. PubMed ID: 19811634
[TBL] [Abstract][Full Text] [Related]
10. Identification of nine alternatively spliced alpha2,3-sialyltransferase, ST3Gal IV, transcripts and analysis of their expression by RT-PCR and laser-induced fluorescent capillary electrophoresis (LIF-CE) in twenty-one human tissues.
Grahn A; Larson G
Glycoconj J; 2001 Oct; 18(10):759-67. PubMed ID: 12441665
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer.
Gretschel S; Haensch W; Schlag PM; Kemmner W
Oncology; 2003; 65(2):139-45. PubMed ID: 12931020
[TBL] [Abstract][Full Text] [Related]
12. Regulation of sialyltransferase expression by estradiol and 4-OH-tamoxifen in the human breast cancer cell MCF-7.
Peyrat JP; Recchi MA; Hebbar M; Pawlowski V; Hornez L; Dong-Lebouhris X; Hondermarck H; Harduin-Lepers A; Delannoy P
Mol Cell Biol Res Commun; 2000 Jan; 3(1):48-52. PubMed ID: 10683317
[TBL] [Abstract][Full Text] [Related]
13. Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix.
Wang PH; Li YF; Juang CM; Lee YR; Chao HT; Tsai YC; Yuan CC
Gynecol Oncol; 2001 Oct; 83(1):121-7. PubMed ID: 11585423
[TBL] [Abstract][Full Text] [Related]
14. Altered mRNA expressions of sialyltransferases in ovarian cancers.
Wang PH; Lee WL; Juang CM; Yang YH; Lo WH; Lai CR; Hsieh SL; Yuan CC
Gynecol Oncol; 2005 Dec; 99(3):631-9. PubMed ID: 16112178
[TBL] [Abstract][Full Text] [Related]
15. MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway.
Pan Y; Hu J; Ma J; Qi X; Zhou H; Miao X; Zheng W; Jia L
Mol Carcinog; 2018 Aug; 57(8):1067-1077. PubMed ID: 29667779
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids.
Okajima T; Fukumoto S; Miyazaki H; Ishida H; Kiso M; Furukawa K; Urano T; Furukawa K
J Biol Chem; 1999 Apr; 274(17):11479-86. PubMed ID: 10206952
[TBL] [Abstract][Full Text] [Related]
17. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer.
Recchi MA; Hebbar M; Hornez L; Harduin-Lepers A; Peyrat JP; Delannoy P
Cancer Res; 1998 Sep; 58(18):4066-70. PubMed ID: 9751611
[TBL] [Abstract][Full Text] [Related]
18. Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis.
Wang PH; Li YF; Juang CM; Lee YR; Chao HT; Ng HT; Tsai YC; Yuan CC
Gynecol Oncol; 2002 Jul; 86(1):45-52. PubMed ID: 12079299
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
Sproviero D; Julien S; Burford B; Taylor-Papadimitriou J; Burchell JM
J Biol Chem; 2012 Dec; 287(53):44490-7. PubMed ID: 23275522
[TBL] [Abstract][Full Text] [Related]
20. Down-regulated expression of RhoA in human conventional renal cell carcinoma.
Pu YS; Wang CW; Liu GY; Kuo YZ; Huang CY; Kang WY; Shun CT; Lin CC; Wu WJ; Hour TC
Anticancer Res; 2008; 28(4B):2039-43. PubMed ID: 18751372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
